# Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial

> **NCT00963976** · PHASE2 · COMPLETED · sponsor: **University of Alberta** · enrollment: 74 (actual)

## Conditions studied

- Intracerebral Hemorrhage

## Interventions

- **DRUG:** labetalol/hydralazine/enalapril

## Key facts

- **NCT ID:** NCT00963976
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2011-12
- **Final completion:** 2012-02
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2012-02-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00963976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00963976, "Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00963976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*